Second, while prior studies have explored cuproptosis-related genes across cancers, our work emphasizes immune correlation and identifies distinctive gene-immune interactions—particularly involving FDX1 and SLC31A1—which were underreported in previous literature. Here, FDX1 is linked to cancer.